We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
In cooperation with Association of Corporate Counsel
  Request new password

Search results

Order by most recent / most popular / relevance

Results: 1-10 of 43

Apotex v Lundbeck, motion to strike pleadings and for security for costs, escitalopram, August 5, 2010

  • Gowling Lafleur Henderson LLP
  • -
  • Canada
  • -
  • September 21 2010

In earlier PMNOC proceedings, Lundbeck successfully obtained an order prohibiting the Minister from issuing a Notice of Compliance to Apotex in respect of its escitalopram product

Eli Lilly v Apotex, PMNOC proceedings, strattera, October 29, 2010

  • Gowling Lafleur Henderson LLP
  • -
  • Canada
  • -
  • November 24 2010

Eli Lilly sought an order of prohibition against Apotex until expiry of its patent for atomoxetine (the '735 patent

Novopharm Limited v. Eli Lilly and Company (2010 FC 915)

  • Gowling Lafleur Henderson LLP
  • -
  • Canada
  • -
  • October 27 2010

An impeachment action was brought by Novopharm in respect of a patent for STRATTERA alleging obviousness, anticipation, utility and improper selection

Eli Lilly Canada Inc. v. Apotex Inc (2010 FCA 240)

  • Gowling Lafleur Henderson LLP
  • -
  • Canada
  • -
  • October 27 2010

This was an appeal of the decision of Madame Justice Gauthier (in the Federal Court) who had found that although Lilly met its burden to prove that Apotex infringed eight Lilly process patents related to the manufacture of the antibiotic cefaclor for material imported before June 3, 1998, Lilly failed to do so for the cefaclor imported into Canada after June 3, 1998

Hospira v Eli Lilly, appeal of order for further and better production of documents, gemcitabine, October 26, 2010

  • Gowling Lafleur Henderson LLP
  • -
  • Canada
  • -
  • November 24 2010

Eli Lilly alleged that gemcitabine made in China and imported into Canada by Hospira infringes Eli Lilly's patent for an intermediate process step in the manufacture of gemcitabine

Sanofi v ratiopharm, PMNOC Regulations decision irbesartan, March 5, 2010

  • Gowling Lafleur Henderson LLP
  • -
  • Canada
  • -
  • May 21 2010

Sanofi sought an order prohibiting the granting of a NOC to ratiopharm

Apotex v. Janssen-Ortho, motion to vary order of Federal Court of Appeal, levofloxacin, August 20, 2010

  • Gowling Lafleur Henderson LLP
  • -
  • Canada
  • -
  • September 21 2010

Apotex filed a Notice of Allegation alleging that a particular patent licensed by Janssen-Ortho was invalid and not infringed

Apotex loses the war in Canada and the battle in England: UK courts rely on Canadian decision to find Apotex acting unlawfully in cCnada has consequences in eErope

  • Gowling Lafleur Henderson LLP
  • -
  • Canada, United Kingdom
  • -
  • October 13 2011

Servier developed perindopril erbumine (“perindopril”) which is a successful long lasting ACE inhibitor sold under the trade-mark COVERSYL

Eli Lilly Canada inc. v. Apotex Inc. (2010 FC 952)

  • Gowling Lafleur Henderson LLP
  • -
  • Canada
  • -
  • October 27 2010

Apotex brought a motion to set aside an Order from 2007 granting Eli Lilly’s applications for a prohibition Order in PMNOC proceedings

Novopharm v Pfizer, motion for interim relief pending appeal, pregabalin, October 5, 2010

  • Gowling Lafleur Henderson LLP
  • -
  • Canada
  • -
  • November 24 2010

See the earlier decisions in this case in the May 2010 and July 2010 editions of this newsletter